CD8A and cancer: The spatial analysis of TNBC with MIBI reported that some patients have predominantly PD-1+CD4+ T-cells whereas others have predominantly PD-1+CD8+ T-cells [24], yet whether this leads to a different anti-cancer response is unclear.